The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes

Glucagon-like peptide-1 receptor (GLP-1R) agonists are a class of newly introduced antidiabetic medications that potentially lower blood glucose by several molecular pathways. DPP-4 inhibitors are the other type of novel antidiabetic medications which act by preventing GLP-1 inactivation and thereby...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Farrokhi, Farin Rashid, Abdalla, Mohammed Altigani, Sathyapalan, Thozhukat, Banach, Maciej, Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263148/
https://www.ncbi.nlm.nih.gov/pubmed/34258291
http://dx.doi.org/10.1155/2021/6518221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263148/
https://www.ncbi.nlm.nih.gov/pubmed/34258291
http://dx.doi.org/10.1155/2021/6518221

Ejemplares similares